STML
Stemline Therapeutics, Inc.
STML
STML
Delisted
STML was delisted on the 9th of June, 2020.
56 hedge funds and large institutions have $184M invested in Stemline Therapeutics, Inc. in 2013 Q2 according to their latest regulatory filings, with 56 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Holders
56
Holders Change
+56
Holders Change %
–
% of All Funds
1.83%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.03%
New
56
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
No buyers this quarter
Top Sellers
No sellers this quarter
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
TRCT
51
Tower Research Capital (TRC)
New York
| $12K | +$12K | +470 | New |
|
52
Barclays
London,
United Kingdom
| $11K | +$11K | +481 | New |
|
53
BlackRock
New York
| $6K | +$6K | +264 | New |
|
54
PNC Financial Services Group
Pittsburgh,
Pennsylvania
| $5K | +$5K | +200 | New |
|
55
Citigroup
New York
| $5K | +$5K | +222 | New |
|
|
SSG
56
Summit Securities Group
New York
| $1K | +$1K | +50 | New |
|